Home › Neurologic Diseases › Minnesota
Neurologic Diseases clinical trials in Minnesota
3 studies for Neurologic Diseases are looking for participants at sites in Minnesota.
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Struthers Parkinson's Center, Golden Valley
- Mayo Clinic in Rochester, Minnesota, Rochester
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Product Surveillance Registry
- Coon Rapids
- Minneapolis
- Robbinsdale
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276Rett Syndrome Registry
- Gillette Children's Specialty Healthcare, Saint Paul
RecruitingObservational study
Ages 0 to 99 · All sexes · Updated Jun 30, 2026 · NCT05432349From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.